Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s interface/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded the term Primary biliary cholangitis and a new Resources entry linking to Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision updated: v3.5.0 added. Revision removed: v3.4.3.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added and the notice about government funding/operating status (previously v3.4.1) was removed. These are maintenance/UI updates rather than changes to trial data or eligibility.SummaryDifference0.5%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.